ChromaDex Inc.;The Regents of the University of California
发明人:
Jeremy Bartos,Ryan Dellinger
申请号：
US14493058
公开号：
US10039725B2
申请日:
2014.09.22
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene.
